AUPH Q3 2017 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000-6.5% YoY

Gross Profit

-$11M-37165.5% margin

Operating Income

-$14M-47551.7% margin

Net Income

-$13M-45241.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-91.2%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$200M

Total Liabilities

$32M

Stockholders' Equity

$168M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$31,000	-6.5%
Gross Profit	-$11M	$30,000	-36026.7%
Operating Income	-$14M	-$5M	-155.8%
Net Income	-$13M	-$7M	-76.8%